FDA Inspection 1220610 — Diwakar Davar, M.D.
The FDA completed an inspection of Diwakar Davar, M.D. on Oct 19, 2023 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 19, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pittsburgh, PA (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7517 | 21 CFR 312.66 | Initial and continuing review |
| 7552 | 21 CFR 312.66 | Changes in research |